|
RPRD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.23810000005354E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.631740E-02 |
| Normal-vs-Stage2 |
1.576020E-02 |
| Normal-vs-Stage3 |
1.83649999996316E-06 |
| Normal-vs-Stage4 |
2.25949999821395E-08 |
| Stage1-vs-Stage2 |
3.224000E-01 |
| Stage1-vs-Stage3 |
4.455500E-03 |
| Stage1-vs-Stage4 |
2.818300E-04 |
| Stage2-vs-Stage3 |
2.982400E-01 |
| Stage2-vs-Stage4 |
5.920400E-02 |
| Stage3-vs-Stage4 |
3.004600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.46979999999742E-05 |
| Normal-vs-AfricanAmerican |
2.51490000047205E-07 |
| Normal-vs-Asian |
3.402800E-01 |
| Caucasian-vs-AfricanAmerican |
1.210250E-02 |
| Caucasian-vs-Asian |
7.349400E-01 |
| AfricanAmerican-vs-Asian |
1.384560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23149999975425E-07 |
| Normal-vs-Female |
3.132400E-02 |
| Male-vs-Female |
4.217700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.118000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.382400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.47100000022793E-07 |
| Normal-vs-Age(81-100Yrs) |
1.229410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.271800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.239800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.049200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.843800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.723400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.660000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.499760E-01 |
| Normal-vs-Grade 2 |
2.710100E-02 |
| Normal-vs-Grade 3 |
2.45169999999462E-05 |
| Normal-vs-Grade 4 |
2.87581070068654E-12 |
| Grade 1-vs-Grade 2 |
7.602400E-02 |
| Grade 1-vs-Grade 3 |
1.003840E-02 |
| Grade 1-vs-Grade 4 |
5.0206000001829E-07 |
| Grade 2-vs-Grade 3 |
3.079600E-02 |
| Grade 2-vs-Grade 4 |
8.51210002483782E-09 |
| Grade 3-vs-Grade 4 |
1.206320E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.982600E-01 |
| Normal-vs-ccB subtype |
2.01100025520873E-10 |
| ccA subtype-vs-ccB subtype |
4.2232883856741E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.366100E-04 |
| Normal-vs-N1 |
1.696210E-02 |
| N0-vs-N1 |
7.464600E-01 |
|
|
